Immune Design Corp.
Utility Patent Applications

Last updated:

List of all Immune Design Corp. patents 8 in total

Status Patent
Application
Utility: RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS External link
Filling date: 7 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS External link
Filling date: 7 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER External link
Filling date: 7 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: A RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS External link
Filling date: 7 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: MATERIALS AND METHODS FOR PRODUCING IMPROVED LENTIVIRAL VECTOR PARTICLES External link
Filling date: 7 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: VACCINES FOR HSV-2 External link
Filling date: 7 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: COMPOSITIONS COMPRISING LENTIVIRAL VECTORS EXPRESSING IL-12 AND METHODS OF USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: GLA Monotherapy for use in Cancer Treatment External link
Filling date: 7 Sep 2025 Issue date: 5 Sep 2019

Showing 1 to 8 of 8 patents.